|
|
|
| Webinar: Revolutionizing Cell Metabolism Monitoring: Inline, Real-Time Glucose and Lactate Analysis | This PHC webinar explores how real-time, inline monitoring of glucose and lactate using PHCbi's LiCellMo® technology can transform bioprocessing and cell therapy. Learn how continuous metabolic analysis improves cell viability, reduces variability, and accelerates decision-making—overcoming the delays and inconsistencies of traditional sampling methods to enhance product quality in biopharma, regenerative medicine, and academic research. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Erin Harris, Editor-In-Chief, Cell & Gene | July’s Cell & Gene Live featured a comprehensive look at the scientific advances, clinical promise, manufacturing hurdles, and regulatory considerations shaping extracellular vesicle and exosome-based therapies. | |
|
|
|
|
|
| A Duplex Assay For Quantification And Qualification Of AAV | Application Note | By Carey Carver, Yotam Blech-Hermoni, and James Qin, QIAGEN | Adeno-associated virus is a key gene therapy vector. Explore how digital PCR offers precise, standard-free quantification with improved consistency and inhibitor tolerance over traditional qPCR methods. |
|
|
|
|
| Multicolor Flow Cytometry Panel Design | Video | BD Biosciences | Watch video series on multicolor flow cytometry to master panel design fundamentals and discover strategies for streamlined, effective panel creation. |
|
|
|
|
| Webinar: Accelerating Cell & Gene Therapy Scale-Up With An Advanced Manufacturing Platform | Discover how Oribiotech and ElevateBio are revolutionizing cell and gene therapy manufacturing with IRO —a next-gen platform delivering superior biological performance, real-time monitoring, and automated scalability. This webinar reveals how closed, efficient systems reduce costs and complexity while boosting consistency and quality from early development to commercialization. Learn how to scale smarter and faster in the evolving CGT landscape. Register here. |
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
Connect With Cell & Gene: |
|
|
|